financetom
Business
financetom
/
Business
/
Liberty Energy Insider Sold Shares Worth $819,800, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Liberty Energy Insider Sold Shares Worth $819,800, According to a Recent SEC Filing
Mar 21, 2024 8:13 AM

10:46 AM EDT, 03/21/2024 (MT Newswires) -- Christopher A Wright, Director, Chairman of the Board & CEO, on March 18, 2024, sold 40,000 shares in Liberty Energy (LBRT) for $819,800. Following the Form 4 filing with the SEC, Wright has control over a total of 2,810,402 shares of the company, with 2,810,402 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1694028/000120919124004996/xslF345X03/doc4.xml

Price: 20.84, Change: +0.26, Percent Change: +1.29

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Cullen/Frost Bankers' Shares Rise on Higher Q4 Earnings, Revenue
Update: Cullen/Frost Bankers' Shares Rise on Higher Q4 Earnings, Revenue
Jan 30, 2025
10:42 AM EST, 01/30/2025 (MT Newswires) -- (Updates with stock move in the headline, first paragraph, and details on a share repurchase program in the fifth paragraph.) Cullen/Frost Bankers ( CFR ) shares rose about 3.4% in recent Thursday trading after the company reported Q4 earnings of $2.36 per diluted share, up from $1.55 a year earlier. Analysts polled by...
What's Going On With Alterity Therapeutics Shares Thursday?
What's Going On With Alterity Therapeutics Shares Thursday?
Jan 30, 2025
Alterity Therapeutics Limited ( ATHE ) shares are moving higher on Thursday after the company reported topline results from its Phase 2 clinical trial of ATH434 in early-stage multiple system atrophy (MSA). ATH434 demonstrated clinically meaningful results in slowing early-stage multiple system atrophy and showed a favorable safety profile. There is currently no FDA-approved, disease altering treatment for MSA. The...
--Huntington Ingalls Keeps Quarterly Dividend at $1.35 a Share, Payable March 14 to Shareholders as of Feb. 28
--Huntington Ingalls Keeps Quarterly Dividend at $1.35 a Share, Payable March 14 to Shareholders as of Feb. 28
Jan 30, 2025
10:38 AM EST, 01/30/2025 (MT Newswires) -- Price: 191.93, Change: -0.96, Percent Change: -0.50 ...
Altria Q4 Earnings Exceed Expectations, Announces $1 Billion Buyback
Altria Q4 Earnings Exceed Expectations, Announces $1 Billion Buyback
Jan 30, 2025
Altria Group, Inc. ( MO ) shares are trading lower Thursday despite quarterly sales of $5.974 billion beating the analyst consensus estimate of $5.046 billion. 2024 was another pivotal year for Altria ( MO ), headlined by meaningful progress toward our Vision, strong financial results and significant cash returns to shareholders, said Billy Gifford, Altria's ( MO ) Chief Executive...
Copyright 2023-2026 - www.financetom.com All Rights Reserved